| Ytd | 826.06% | |
| 1y | 716.77% |
| Open | 13.17 | Prev Close | 13.23 | Low | 13.11 | High | 13.30 | Mkt Cap | 698.00M |
| Vol | 669.00 | Avg Vol | 180.19K | EPS | -1.39 | P/E | -9.46 | Forward P/E | -1.42 |
| Beta | 1.06 | Short Ratio | 0.09 | Inst. Own | 0.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-22 | 50-d Avg | 11.35 | 200-d Avg | 7.82 | 1yr Est | 9.00 |
ANL News
Adlai Nortye (NASDAQ: ANL - Get Free Report) is projected to announce its Q2 2026 resultson Thursday
First-in-class pan-RAS(ON) ADC is cleared for clinical developmentDesigned to selectively deliver pa
First-in-class pan-RAS(ON) ADC is cleared for clinical development Designed to selectively deliver p
"Dosing the first U.S. patient with AN9025 on an intermittent weekly schedule is a significant m
First patient dosed in intermittent QW dosing arm with AN9025 Intermittent dosing offers a different
SINGAPORE and NORTH BRUNSWICK, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: AN
US stock futures up, Dow futures gain 100+ points. Concentrix Corp (CNXC) shares down 24% after weak
Oppenheimer analyst Jay Olson initiates coverage on Adlai Nortye (NASDAQ:ANL) with a Outperform r
Adlai Nortye Ltd. Sponsored ADR (ANL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing
Jones Trading analyst Boris Peaker initiates coverage on Adlai Nortye (NASDAQ:ANL) with a Buy rat
Adlai Nortye Ltd. Sponsored ADR (ANL) appears to have found support after losing some value lately,
Here is how ANI Pharmaceuticals (ANIP) and Adlai Nortye Ltd. Sponsored ADR (ANL) have performed comp
Top analysts change outlook on top names: Truist cut Doximity's price target, Stifel raised Plex
HC Wainwright & Co. analyst Joseph Pantginis maintains Adlai Nortye (NASDAQ:ANL) with a Buy a
Adlai Nortye Ltd. (NASDAQ:ANL) (the "Company" or "Adlai Nortye"), a clinical-stage b
SINGAPORE and NORTH BRUNSWICK, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (Nasdaq: A
US stock futures down, TeraWulf Inc. (WULF) shares fall after preliminary results & stock offeri
Dow futures down 0.1%. FGI Industries (NASDAQ: FGI) reported mixed results for Q4, with losses of 29
Adlai Nortye Ltd. Sponsored ADR (ANL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing
Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Cardinal Health (CAH) have performed compared
Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Cardinal Health (CAH) have performed compared
HC Wainwright & Co. analyst Joseph Pantginis upgrades Adlai Nortye (NASDAQ:ANL) from Neutral
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Adlai Nor
Adlai Nortye Ltd. (NASDAQ:ANL) (the "Company" or "Adlai Nortye"), a clinical-stage b
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Adlai Nor
Adlai Nortye Ltd. Sponsored ADR (NASDAQ: ANL - Get Free Report) saw a significant drop in short inte
Pharming Group (NASDAQ: PHAR - Get Free Report) and Adlai Nortye (NASDAQ: ANL - Get Free Report) are
Under the terms of the agreement, ASK Pharm will obtain exclusive rights to develop, manufacture, an
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Adlai Nor
Adlai Nortye Ltd. Sponsored ADR (NASDAQ: ANL - Get Free Report) was the target of a significant drop